These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8878950)

  • 1. Colonisation of cystic fibrosis patients by non-mucoid Pseudomonas aeruginosa--characterisation of the alginate from mucoid variants.
    Tatnell PJ; Russell NJ; Govan JR; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):406S. PubMed ID: 8878950
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterisation of alginates from mucoid strains of Pseudomonas aeruginosa.
    Tatnell PJ; Russell NJ; Govan JR; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):404S. PubMed ID: 8878948
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of the Klebsiella pneumoniae alginate lyase gene in Pseudomonas aeruginosa--effect on alginate structure.
    Tatnell PJ; Goldberg JB; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):407S. PubMed ID: 8878951
    [No Abstract]   [Full Text] [Related]  

  • 4. Overexpression of the GDP-mannose dehydrogenase gene from Pseudomonas aeruginosa.
    Tatnell PJ; Russell NJ; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):405S. PubMed ID: 8878949
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical analysis of alginates from mucoid strains of Pseudomonas aeruginosa.
    Tatnell PJ; Russell NJ; Gacesa P
    Biochem Soc Trans; 1994 Aug; 22(3):310S. PubMed ID: 7821569
    [No Abstract]   [Full Text] [Related]  

  • 6. Mucoid Pseudomonas aeruginosa in cystic fibrosis: signal transduction and histone-like elements in the regulation of bacterial virulence.
    Deretic V; Mohr CD; Martin DW
    Mol Microbiol; 1991 Jul; 5(7):1577-83. PubMed ID: 1943693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.
    Song Z; Wu H; Ciofu O; Kong KF; Høiby N; Rygaard J; Kharazmi A; Mathee K
    J Med Microbiol; 2003 Sep; 52(Pt 9):731-740. PubMed ID: 12909647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
    Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
    Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Høiby N; Espersen F; Koch C
    Thorax; 1992 Jan; 47(1):6-13. PubMed ID: 1539148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
    Gill JF; Deretic V; Chakrabarty AM
    Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.
    Ohman DE; Chakrabarty AM
    Infect Immun; 1982 Aug; 37(2):662-9. PubMed ID: 6811437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis.
    Pier GB; Coleman F; Grout M; Franklin M; Ohman DE
    Infect Immun; 2001 Mar; 69(3):1895-901. PubMed ID: 11179370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.
    May TB; Shinabarger D; Maharaj R; Kato J; Chu L; DeVault JD; Roychoudhury S; Zielinski NA; Berry A; Rothmel RK
    Clin Microbiol Rev; 1991 Apr; 4(2):191-206. PubMed ID: 1906371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of alginate-producing Pseudomonas aeruginosa on alveolar macrophage apoptotic cell clearance.
    McCaslin CA; Petrusca DN; Poirier C; Serban KA; Anderson GG; Petrache I
    J Cyst Fibros; 2015 Jan; 14(1):70-77. PubMed ID: 25027418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry and biology of the alginate of mucoid strains of Pseudomonas aeruginosa in cystic fibrosis.
    Russell NJ; Gacesa P
    Mol Aspects Med; 1988; 10(1):1-91. PubMed ID: 3129631
    [No Abstract]   [Full Text] [Related]  

  • 18. The mucoid switch in Pseudomonas aeruginosa represses quorum sensing systems and leads to complex changes to stationary phase virulence factor regulation.
    Ryall B; Carrara M; Zlosnik JE; Behrends V; Lee X; Wong Z; Lougheed KE; Williams HD
    PLoS One; 2014; 9(5):e96166. PubMed ID: 24852379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis.
    Gómez MI; Prince A
    Curr Opin Pharmacol; 2007 Jun; 7(3):244-51. PubMed ID: 17418640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both?
    Eber E; Zach MS
    Thorax; 2010 Oct; 65(10):849-51. PubMed ID: 20861286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.